Another Option for Rare Benign Soft-Tissue Tumor Wins FDA Approval

Who is covering this

1. Medpagetoday Center Factuality: Mostly factual US 2 hours ago
   Another Option for Rare Benign Soft-Tissue Tumor Wins FDA Approval

   (MedPage Today) -- The FDA approved the small-molecule inhibitor pimicotinib (Pimjetmi) for selected patients with symptomatic tenosynovial giant cell tumor (TGCT) and high surgical risk. An oral selective inhibitor of colony stimulating factor...